Glutamatergic neuroplasticity in cocaine addiction

Progress in Molecular Biology and Translational Science

Volumn 98, Issue C, 2011, Pages 367-400

  Uys, Joachim D ^a   Reissner, Kathryn J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Addiction; Cocaine; Cystineglutamate exchanger; Glutamate; Glutathione S Transferase pi; Metabotropic glutamate receptors; Nucleus accumbens; Prefrontal cortex; Redox; S glutathionylation

Indexed keywords

EID: 78650890701     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385506-0.00009-0     Document Type: Chapter

References (229)

1. United Nations Office on Drugs and Crime (2009) World Drug Report, Vienna
2. G.F. Koob, G. Kenneth Lloyd, and B.J. Mason Development of pharmacotherapies for drug addiction: a Rosetta stone approach Nat Rev Drug Discov 8 2009 500 515
3. G.R. Uhl, and R.W. Grow The burden of complex genetics in brain disorders Arch Gen Psychiatry 61 2004 223 229
4. M. Behnke, F.D. Eyler, M. Conlon, O.Q. Casanova, and N.S. Woods How fetal cocaine exposure increases neonatal hospital costs Pediatrics 99 1997 204 208
5. P.B. Santora, and H.E. Hutton Longitudinal trends in hospital admissions with co-occurring alcohol/drug diagnoses, 19942002 J Subst Abuse Treat 35 2008 1 12
6. B. Han, J.C. Gfroerer, and J.D. Colliver Associations between duration of illicit drug use and health conditions: results from the 2005-2007 national surveys on drug use and health Ann Epidemiol 20 2010 289 297
7. P.W. Kalivas, and C. O'Brien Drug addiction as a pathology of staged neuroplasticity Neuropsychopharmacology 33 2008 166 180
8. K.C. Berridge, and T.E. Robinson What is the role of dopamine in reward: hedonic impact reward learning or incentive salience? Brain Res Brain Res Rev 28 1998 309 369
9. S.E. Hyman, and R.C. Malenka Addiction and the brain: the neurobiology of compulsion and its persistence Nat Rev Neurosci 2 2001 695 703
10. R.A. Wise Dopamine and reward: the anhedonia hypothesis 30 years on Neurotox Res 14 2008 169 183
11. P.W. Kalivas The glutamate homeostasis hypothesis of addiction Nat Rev Neurosci 10 2009 561 572
12. D.H. Epstein, K.L. Preston, J. Stewart, and Y. Shaham Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure Psychopharmacol Berl 189 2006 1 16
13. Y. Shaham, U. Shalev, L. Lu, H. De Wit, and J. Stewart The reinstatement model of drug relapse: history, methodology and major findings Psychopharmacol Berl 168 2003 3 20
14. R.M. Post, and H. Rose Increasing effects of repetitive cocaine administration in the rat Nature 260 1976 731 732
15. P.W. Kalivas, B.A. Sorg, and M.S. Hooks The pharmacology and neural circuitry of sensitization to psychostimulants Behav Pharmacol 4 1993 315 334
16. P.W. Kalivas, and J. Stewart Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity Brain Res Brain Res Rev 16 1991 223 244
17. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res Brain Res Rev 18 1993 247 291
18. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85 1988 5274 5278
19. S. Spiga, A. Lintas, and M. Diana Addiction and cognitive functions Ann NY Acad Sci 1139 2008 299 306
20. N.D. Volkow, J.S. Fowler, G.J. Wang, and J.M. Swanson Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Mol Psychiatry 9 2004 557 569
21. R.A. Fuchs, K.A. Evans, C.C. Ledford, M.P. Parker, J.M. Case, and R.H. Mehta The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats Neuropsychopharmacology 30 2005 296 309
22. X. Xie, D.R. Ramirez, H.C. Lasseter, and R.A. Fuchs Effects of mGluR1 antagonism in the dorsal hippocampus on drug context-induced reinstatement of cocaine-seeking behavior in rats Psychopharmacol Berl 208 2010 1 11
23. Y. Shaham, S. Erb, and J. Stewart Stress-induced relapse to heroin and cocaine seeking in rats: a review Brain Res Brain Res Rev 33 2000 13 33
24. R.E. See Neural substrates of conditioned-cued relapse to drug-seeking behavior Pharmacol Biochem Behav 71 2002 517 529
25. R.E. See Neural substrates of cocaine-cue associations that trigger relapse Eur J Pharmacol 526 2005 140 146
26. R.E. See, R.A. Fuchs, C.C. Ledford, and J. McLaughlin Drug addiction, relapse, and the amygdala Ann NY Acad Sci 985 2003 294 307
27. S.R. Sesack, and A.A. Grace Cortico-basal ganglia reward network: microcircuitry Neuropsychopharmacology 35 2010 27 47
28. S.R. Sesack, and D.B. Carr Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia Physiol Behav 77 2002 513 517
29. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
30. G.F. Koob A role for brain stress systems in addiction Neuron 59 2008 11 34
31. G.F. Koob, and M. Le Moal Plasticity of reward neurocircuitry and the 'dark side' of drug addiction Nat Neurosci 8 2005 1442 1444
32. R.T. Lalumiere, and P.W. KAlivas Reward and drugs of abuse R.P. Kesner, J.L. Martinez, Neurobiology of Learning and Memory 2007 Academic Press, New York, NY 459 482
33. P.W. Kalivas, and N.D. Volkow The neural basis of addiction: a pathology of motivation and choice Am J Psychiatry 162 2005 1403 1413
34. A.E. Kelley Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning Neurosci Biobehav Rev 27 2004 765 776
35. J. Peters, R.T. LaLumiere, and P.W. Kalivas Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats J Neurosci 28 2008 6046 6053
36. R.T. LaLumiere, K.E. Niehoff, and P.W. Kalivas The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration Learn Mem 17 2010 168 175
37. J. Peters, P.W. Kalivas, and G.J. Quirk Extinction circuits for fear and addiction overlap in prefrontal cortex Learn Mem 16 2009 279 288
38. V. Kumaresan, M. Yuan, J. Yee, K.R. Famous, S.M. Anderson, and H.D. Schmidt Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking Behav Brain Res 202 2009 238 244
39. R.K. Bachtell, K. Whisler, D. Karanian, and D.W. Self Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat Psychopharmacol Berl 183 2005 41 53
40. H.D. Schmidt, S.M. Anderson, and R.C. Pierce Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat Eur J Neurosci 23 2006 219 228
41. S.M. Anderson, H.D. Schmidt, and R.C. Pierce Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking Neuropsychopharmacology 31 2006 1452 1461
42. T.W. Robbins, K.D. Ersche, and B.J. Everitt Drug addiction and the memory systems of the brain Ann NY Acad Sci 1141 2008 1 21
43. B.J. Everitt, and T.W. Robbins Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat Neurosci 8 2005 1481 1489
44. L.L. Howell, and K.M. Wilcox Functional imaging and neurochemical correlates of stimulant self-administration in primates Psychopharmacol Berl 163 2002 352 361
45. N.D. Volkow, J.S. Fowler, G.J. Wang, J.M. Swanson, and F. Telang Dopamine in drug abuse and addiction: results of imaging studies and treatment implications Arch Neurol 64 2007 1575 1579
46. P.W. Kalivas, N. Volkow, and J. Seamans Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission Neuron 45 2005 647 650
47. N.D. Volkow, G.J. Wang, Y. Ma, J.S. Fowler, C. Wong, and Y.S. Ding Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction J Neurosci 25 2005 3932 3939
48. S. Grant, E.D. London, D.B. Newlin, V.L. Villemagne, X. Liu, and C. Contoreggi Activation of memory circuits during cue-elicited cocaine craving Proc Natl Acad Sci USA 93 1996 12040 12045
49. A.R. Childress, P.D. Mozley, W. McElgin, J. Fitzgerald, M. Reivich, and C.P. O'Brien Limbic activation during cue-induced cocaine craving Am J Psychiatry 156 1999 11 18
50. G.J. Wang, N.D. Volkow, J.S. Fowler, P. Cervany, R.J. Hitzemann, and N.R. Pappas Regional brain metabolic activation during craving elicited by recall of previous drug experiences Life Sci 64 1999 775 784
51. C. Martin-Soelch, A.F. Chevalley, G. Kunig, J. Missimer, S. Magyar, and A. Mino Changes in reward-induced brain activation in opiate addicts Eur J Neurosci 14 2001 1360 1368
52. K. McFarland, C.C. Lapish, and P.W. Kalivas Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior J Neurosci 23 2003 3531 3537
53. M.E. Wolf, and C.R. Ferrario AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine Neurosci Biobehav Rev 35 2 2010 185 211
54. J.A. Kauer, and R.C. Malenka Synaptic plasticity and addiction Nat Rev Neurosci 8 2007 844 858
55. M.S. Bowers, B.T. Chen, and A. Bonci AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future Neuron 67 2010 11 24
56. M.A. Ungless, J.L. Whistler, R.C. Malenka, and A. Bonci Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons Nature 411 2001 583 587
57. E. Argilli, D.R. Sibley, R.C. Malenka, P.M. England, and A. Bonci Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area J Neurosci 28 2008 9092 9100
58. S.L. Borgland, R.C. Malenka, and A. Bonci Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats J Neurosci 24 2004 7482 7490
59. B.T. Chen, M.S. Bowers, M. Martin, F.W. Hopf, A.M. Guillory, and R.M. Carelli Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA Neuron 59 2008 288 297
60. M. Mameli, B. Halbout, C. Creton, D. Engblom, J.R. Parkitna, and R. Spanagel Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc Nat Neurosci 12 2009 1036 1041
61. K. Moussawi, A. Pacchioni, M. Moran, M.F. Olive, J.T. Gass, and A. Lavin N-Acetylcysteine reverses cocaine-induced metaplasticity Nat Neurosci 12 2009 182 189
62. M. Martin, B.T. Chen, F.W. Hopf, M.S. Bowers, and A. Bonci Cocaine self-administration selectively abolishes LTD in the core of the nucleus accumbens Nat Neurosci 9 2006 868 869
63. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th edition 2000 American Psychiatric Association Washington, D.C text revised
64. F. Kasanetz, V. Deroche-Gamonet, N. Berson, E. Balado, M. Lafourcade, and O. Manzoni Transition to addiction is associated with a persistent impairment in synaptic plasticity Science 328 2010 1709 1712
65. M.J. Thomas, C. Beurrier, A. Bonci, and R.C. Malenka Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine Nat Neurosci 4 2001 1217 1223
66. S. Kourrich, P.E. Rothwell, J.R. Klug, and M.J. Thomas Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens J Neurosci 27 2007 7921 7928
67. H.W. Shen, S. Toda, K. Moussawi, A. Bouknight, D.S. Zahm, and P.W. Kalivas Altered dendritic spine plasticity in cocaine-withdrawn rats J Neurosci 29 2009 2876 2884
68. N. Suto, L.E. Ecke, and R.A. Wise Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens Psychopharmacol Berl 205 2009 431 439
69. R.T. LaLumiere, and P.W. Kalivas Glutamate release in the nucleus accumbens core is necessary for heroin seeking J Neurosci 28 2008 3170 3177
70. J.L. Cornish, and P.W. Kalivas Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction J Neurosci 20 2000 RC89
71. P. Di Ciano, R.N. Cardinal, R.A. Cowell, S.J. Little, and B.J. Everitt Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior J Neurosci 21 2001 9471 9477
72. A. Ping, J. Xi, B.M. Prasad, M.H. Wang, and P.J. Kruzich Contributions of nucleus accumbens core and shell GluR1 containing AMPA receptors in AMPA- and cocaine-primed reinstatement of cocaine-seeking behavior Brain Res 1215 2008 173 182
73. P. Backstrom, and P. Hyytia Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats Psychopharmacol Berl 192 2007 571 580
74. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol Rev 51 1999 7 61
75. K.L. Conrad, K.Y. Tseng, J.L. Uejima, J.M. Reimers, L.J. Heng, and Y. Shaham Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving Nature 454 2008 118 121
76. J.W. Grimm, B.T. Hope, R.A. Wise, and Y. Shaham Neuroadaptation: incubation cocaine craving after withdrawal Nature 412 2001 141 142
77. L. Lu, J.W. Grimm, B.T. Hope, and Y. Shaham Incubation of cocaine craving after withdrawal: a review of preclinical data Neuropharmacology 47 Suppl 1 2004 214 226
78. S.M. Anderson, K.R. Famous, G. Sadri-Vakili, V. Kumaresan, H.D. Schmidt, and C.E. Bass CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking Nat Neurosci 11 2008 344 353
79. K.R. Famous, V. Kumaresan, G. Sadri-Vakili, H.D. Schmidt, D.F. Mierke, and J.H. Cha Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking J Neurosci 28 2008 11061 11070
80. H.D. Schmidt, and R.C. Pierce Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction Ann NY Acad Sci 1187 2010 35 75
81. Y.Y. Ma, C. Cepeda, and C.L. Cui The role of striatal NMDA receptors in drug addiction Int Rev Neurobiol 89 2009 131 146
82. R. Shigemoto, A. Kinoshita, E. Wada, S. Nomura, H. Ohishi, and M. Takada Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus J Neurosci 17 1997 7503 7522
83. Y. Tamaru, S. Nomura, N. Mizuno, and R. Shigemoto Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites Neuroscience 106 2001 481 503
84. C.M. Testa, I.K. Friberg, S.W. Weiss, and D.G. Standaert Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia J Comp Neurol 390 1998 5 19
85. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J Neurochem 75 2000 889 907
86. R. Anwyl Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res Brain Res Rev 29 1999 83 120
87. N.E. Paterson, and A. Markou The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats Psychopharmacol Berl 179 2005 255 261
88. P. Backstrom, D. Bachteler, S. Koch, P. Hyytia, and R. Spanagel mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior Neuropsychopharmacology 29 2004 921 928
89. J.T. Gass, M.P. Osborne, N.L. Watson, J.L. Brown, and M.F. Olive mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats Neuropsychopharmacology 34 2009 820 833
90. F.I. Carroll Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction Ann NY Acad Sci 1141 2008 221 232
91. J. Besheer, S. Faccidomo, J.J. Grondin, and C.W. Hodge Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats Alcohol Clin Exp Res 32 2008 209 221
92. M.E. Liechti, and A. Markou Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies CNS Drugs 22 2008 705 724
93. D.M. Platt, J.K. Rowlett, and R.D. Spealman Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine Psychopharmacol Berl 200 2008 167 176
94. C. Chiamulera, M.P. Epping-Jordan, A. Zocchi, C. Marcon, C. Cottiny, and S. Tacconi Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice Nat Neurosci 4 2001 873 874
95. Z.X. Xi, S. Ramamoorthy, D.A. Baker, H. Shen, D.J. Samuvel, and P.W. Kalivas Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine J Pharmacol Exp Ther 303 2002 608 615
96. X. Xie, and J.D. Steketee Repeated exposure to cocaine alters the modulation of mesocorticolimbic glutamate transmission by medial prefrontal cortex Group II metabotropic glutamate receptors J Neurochem 107 2008 186 196
97. M.E. Liechti, L. Lhuillier, K. Kaupmann, and A. Markou Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence J Neurosci 27 2007 9077 9085
98. K. Moussawi, and P.W. Kalivas Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction Eur J Pharmacol 639 2010 115 122
99. J.M. Bossert, S.M. Gray, L. Lu, and Y. Shaham Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking Neuropsychopharmacology 31 2006 2197 2209
100. J.M. Bossert, R.F. Busch, and S.M. Gray The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking Neuroreport 16 2005 1013 1016
101. J. Peters, and P.W. Kalivas The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats Psychopharmacol Berl 186 2006 143 149
102. X. Xie, and J.D. Steketee Effects of repeated exposure to cocaine on group II metabotropic glutamate receptor function in the rat medial prefrontal cortex: behavioral and neurochemical studies Psychopharmacol Berl 203 2009 501 510
103. Y. Zhao, C.V. Dayas, H. Aujla, M.A. Baptista, R. Martin-Fardon, and F. Weiss Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala J Neurosci 26 2006 9967 9974
104. Y. Morishima, T. Miyakawa, T. Furuyashiki, Y. Tanaka, H. Mizuma, and S. Nakanishi Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice Proc Natl Acad Sci USA 102 2005 4170 4175
105. P.R. Brakeman, A.A. Lanahan, R. O'Brien, K. Roche, C.A. Barnes, and R.L. Huganir Homer: a protein that selectively binds metabotropic glutamate receptors Nature 386 1997 284 288
106. J. Lu, T.D. Helton, T.A. Blanpied, B. Racz, T.M. Newpher, and R.J. Weinberg Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to Homer Neuron 55 2007 874 889
107. J.C. Tu, B. Xiao, S. Naisbitt, J.P. Yuan, R.S. Petralia, and P. Brakeman Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins Neuron 23 1999 583 592
108. J.C. Tu, B. Xiao, J.P. Yuan, A.A. Lanahan, K. Leoffert, and M. Li Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors Neuron 21 1998 717 726
109. K.K. Szumlinski, K.E. Abernathy, E.B. Oleson, M. Klugmann, K.D. Lominac, and D.Y. He Homer isoforms differentially regulate cocaine-induced neuroplasticity Neuropsychopharmacology 31 2006 768 777
110. L.A. Knackstedt, K. Moussawi, R. Lalumiere, M. Schwendt, M. Klugmann, and P.W. Kalivas Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking J Neurosci 30 2010 7984 7992
111. K.K. Szumlinski, P.W. Kalivas, and P.F. Worley Homer proteins: implications for neuropsychiatric disorders Curr Opin Neurobiol 16 2006 251 257
112. K.K. Szumlinski, M.H. Dehoff, S.H. Kang, K.A. Frys, K.D. Lominac, and M. Klugmann Homer proteins regulate sensitivity to cocaine Neuron 43 2004 401 413
113. S.M. Lanier AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins Biol Cell 96 2004 369 372
114. M.S. Bowers, F.W. Hopf, J.K. Chou, A.M. Guillory, S.J. Chang, and P.H. Janak Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma Proc Natl Acad Sci USA 105 2008 12533 12538
115. P. Fan, Z. Jiang, I. Diamond, and L. Yao Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons Mol Pharmacol 76 2009 526 533
116. M.S. Bowers, K. McFarland, R.W. Lake, Y.K. Peterson, C.C. Lapish, and M.L. Gregory Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking Neuron 42 2004 269 281
117. L. Yao, K. McFarland, P. Fan, Z. Jiang, Y. Inoue, and I. Diamond Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior Proc Natl Acad Sci USA 102 2005 8746 8751
118. S.J. Russo, M.S. Mazei-Robison, J.L. Ables, and E.J. Nestler Neurotrophic factors and structural plasticity in addiction Neuropharmacology 56 Suppl 1 2009 73 82
119. J.Q. Wang, E.E. Fibuch, and L. Mao Regulation of mitogen-activated protein kinases by glutamate receptors J Neurochem 100 2007 1 11
120. M.B. Ghasemzadeh, L.K. Windham, R.W. Lake, C.J. Acker, and P.W. Kalivas Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling Synapse 63 2009 42 53
121. S.J. Russo, D.M. Dietz, D. Dumitriu, J.H. Morrison, R.C. Malenka, and E.J. Nestler The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens Trends Neurosci 33 2010 267 276
122. T.E. Robinson, and B. Kolb Structural plasticity associated with exposure to drugs of abuse Neuropharmacology 47 Suppl 1 2004 33 46
123. S. Pulipparacharuvil, W. Renthal, C.F. Hale, M. Taniguchi, G. Xiao, and A. Kumar Cocaine regulates MEF2 to control synaptic and behavioral plasticity Neuron 59 2008 621 633
124. K.W. Lee, Y. Kim, A.M. Kim, K. Helmin, A.C. Nairn, and P. Greengard Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens Proc Natl Acad Sci USA 103 2006 3399 3404
125. C.R. Ferrario, G. Gorny, H.S. Crombag, Y. Li, B. Kolb, and T.E. Robinson Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use Biol Psychiatry 58 2005 751 759
126. S.D. Norrholm, J.A. Bibb, E.J. Nestler, C.C. Ouimet, J.R. Taylor, and P. Greengard Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5 Neuroscience 116 2003 19 22
127. H. Shen, S.R. Sesack, S. Toda, and P.W. Kalivas Automated quantification of dendritic spine density and spine head diameter in medium spiny neurons of the nucleus accumbens Brain Struct Funct 213 2008 149 157
128. W.D. Yao, R.D. Spealman, and J. Zhang Dopaminergic signaling in dendritic spines Biochem Pharmacol 75 2008 2055 2069
129. T.E. Robinson, and B. Kolb Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine J Neurosci 17 1997 8491 8497
130. M.A. Herman, and C.E. Jahr Extracellular glutamate concentration in hippocampal slice J Neurosci 27 2007 9736 9741
131. B. Barbour An evaluation of synapse independence J Neurosci 21 2001 7969 7984
132. J.S. Diamond, and C.E. Jahr Transporters buffer synaptically released glutamate on a submillisecond time scale J Neurosci 17 1997 4672 4687
133. O. Warr, M. Takahashi, and D. Attwell Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange J Physiol 514 Pt 3 1999 783 793
134. P.G. Haydon GLIA: listening and talking to the synapse Nat Rev Neurosci 2 2001 185 193
135. W. Timmerman, and B.H. Westerink Brain microdialysis of GABA and glutamate: what does it signify? Synapse 27 1997 242 261
136. N.C. Danbolt Glutamate uptake Prog Neurobiol 65 2001 1 105
137. D.A. Baker, K. McFarland, R.W. Lake, H. Shen, X.C. Tang, and S. Toda Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse Nat Neurosci 6 2003 743 749
138. P.W. Kalivas, K. McFarland, S. Bowers, K. Szumlinski, Z.X. Xi, and D. Baker Glutamate transmission and addiction to cocaine Ann NY Acad Sci 1003 2003 169 175
139. M.M. Moran, K. McFarland, R.I. Melendez, P.W. Kalivas, and J.K. Seamans Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking J Neurosci 25 2005 6389 6393
140. K. McFarland, S.B. Davidge, C.C. Lapish, and P.W. Kalivas Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior J Neurosci 24 2004 1551 1560
141. D.A. Baker, Z.X. Xi, H. Shen, C.J. Swanson, and P.W. Kalivas The origin and neuronal function of in vivo nonsynaptic glutamate J Neurosci 22 2002 9134 9141
142. L.A. Knackstedt, R.I. Melendez, and P.W. Kalivas Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking Biol Psychiatry 67 2010 81 84
143. T. Cunha-Oliveira, A.C. Rego, and C.R. Oliveira Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs Brain Res Rev 58 2008 192 208
144. J.J. Mieyal, M.M. Gallogly, S. Qanungo, E.A. Sabens, and M.D. Shelton Molecular mechanisms and clinical implications of reversible protein S-glutathionylation Antioxid Redox Signal 10 2008 1941 1988
145. D.M. Townsend S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response Mol Interv 7 2007 313 324
146. S.J. Chinta, S. Rajagopalan, D.A. Butterfield, and J.K. Andersen In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's disease Neurosci Lett 402 2006 137 141
147. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, Y. Agid, and F. Javoy-Agid Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 1994 348 355
148. F. Di Domenico, G. Cenini, R. Sultana, M. Perluigi, D. Uberti, and M. Memo Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis Neurochem Res 34 2009 727 733
149. Y. Zhu, P.M. Carvey, and Z. Ling Age-related changes in glutathione and glutathione-related enzymes in rat brain Brain Res 1090 2006 35 44
150. N. Klepac, M. Relja, R. Klepac, S. Hecimovic, T. Babic, and V. Trkulja Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study J Neurol 254 2007 1676 1683
151. P. Steullet, H.C. Neijt, M. Cuenod, and K.Q. Do Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia Neuroscience 137 2006 807 819
152. N.V. Radonjic, I.D. Knezevic, U. Vilimanovich, T. Kravic-Stevovic, L.V. Marina, and T. Nikolic Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration Neuropharmacology 58 2010 739 745
153. M. Raffa, A. Mechri, L.B. Othman, C. Fendri, L. Gaha, and A. Kerkeni Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1178 1183
154. F.Q. Schafer, and G.R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple Free Radic Biol Med 30 2001 1191 1212
155. D.P. Jones, J.L. Carlson, V.C. Mody, J. Cai, M.J. Lynn, and P. Sternberg Redox state of glutathione in human plasma Free Radic Biol Med 28 2000 625 635
156. J.D. Uys, Y. Manevich, L.C. Devane, L. He, T.E. Garret, and C.J. Pazoles Preclinical pharmacokinetic analysis of NOV-002, a glutathione disulfide mimetic Biomed Pharmacother 64 7 2010 493 4698
157. H.R. Lopez-Mirabal, and J.R. Winther Redox characteristics of the eukaryotic cytosol Biochim Biophys Acta 1783 2008 629 640
158. W.G. Kirlin, J. Cai, S.A. Thompson, D. Diaz, T.J. Kavanagh, and D.P. Jones Glutathione redox potential in response to differentiation and enzyme inducers Free Radic Biol Med 27 1999 1208 1218
159. R.E. Hansen, D. Roth, and J.R. Winther Quantifying the global cellular thiol-disulfide status Proc Natl Acad Sci USA 106 2009 422 427
160. M.J. Thomas, P.W. Kalivas, and Y. Shaham Neuroplasticity in the mesolimbic dopamine system and cocaine addiction Br J Pharmacol 154 2008 327 342
161. N. Guo, C. McIntosh, and C. Shaw Glutathione: new candidate neuropeptide in the central nervous system Neuroscience 51 1992 835 842
162. N. Guo, and C. Shaw Characterization and localization of glutathione binding sites on cultured astrocytes Brain Res Mol Brain Res 15 1992 207 215
163. T.Y. Chin, S.H. Chueh, and P.L. Tao S-Nitrosoglutathione and glutathione act as NMDA receptor agonists in cultured hippocampal neurons Acta Pharmacol Sin 27 2006 853 860
164. R. Janaky, K. Ogita, B.A. Pasqualotto, J.S. Bains, S.S. Oja, and Y. Yoneda Glutathione and signal transduction in the mammalian CNS J Neurochem 73 1999 889 902
165. R. Dringen, B. Pfeiffer, and B. Hamprecht Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione J Neurosci 19 1999 562 569
166. E. O'Connor, A. Devesa, C. Garcia, I.R. Puertes, A. Pellin, and J.R. Vina Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of l-cystine and ascorbate Brain Res 680 1995 157 163
167. A. Madayag, D. Lobner, K.S. Kau, J.R. Mantsch, O. Abdulhameed, and M. Hearing Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine J Neurosci 27 2007 13968 13976
168. A. Madayag, K.S. Kau, D. Lobner, J.R. Mantsch, S. Wisniewski, and D.A. Baker Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats J Neurosci. 30 1 2010 210 217
169. D.M. Townsend, Y. Manevich, L. He, S. Hutchens, C.J. Pazoles, and K.D. Tew Novel role for glutathione S-transferase pi. Regulator protein S Glutathionylation following oxidative nitrosative stress J Biol Chem 284 2009 436 445
170. M. Castro-Caldas, A. Neves Carvalho, I. Peixeiro, E. Rodrigues, M.C. Lechner, and M.J. Gama GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum J Mol Neurosci 38 2009 114 127
171. M. Smeyne, J. Boyd, K. Raviie Shepherd, Y. Jiao, B.B. Pond, and M. Hatler GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism Proc Natl Acad Sci USA 104 2007 1977 1982
172. M. Shi, J. Bradner, T.K. Bammler, D.L. Eaton, J. Zhang, and Z. Ye Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression Am J Pathol 175 2009 54 65
173. R. Vilar, H. Coelho, E. Rodrigues, M.J. Gama, I. Rivera, and E. Taioli Association of A313 G polymorphism (GSTP1*B) in the glutathione-S- transferase P1 gene with sporadic Parkinson's disease Eur J Neurol 14 2007 156 161
174. C. Guindalini, C. O'Gara, R. Laranjeira, D. Collier, A. Castelo, and H. Vallada A GSTP1 functional variant associated with cocaine dependence in a Brazilian population Pharmacogenet Genomics 15 2005 891 893
175. S.R. Tannenbaum, and F.M. White Regulation and specificity of S-nitrosylation and denitrosylation ACS Chem Biol 1 2006 615 618
176. R.J. Mallis, M.J. Hamann, W. Zhao, T. Zhang, S. Hendrich, and J.A. Thomas Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats Biol Chem 383 2002 649 662
177. H.O. Morishima, R.A. Whittington, A. Iso, and T.B. Cooper The comparative toxicity of cocaine and its metabolites in conscious rats Anesthesiology 90 1999 1684 1690
178. V.J. Findlay, D.M. Townsend, T.E. Morris, J.P. Fraser, L. He, and K.D. Tew A novel role for human sulfiredoxin in the reversal of glutathionylation Cancer Res 66 2006 6800 6806
179. I. Carlberg, and B. Mannervik Purification and characterization of the flavoenzyme glutathione reductase from rat liver J Biol Chem 250 1975 5475 5480
180. S.D. LaRowe, H. Myrick, S. Hedden, P. Mardikian, M. Saladin, and A. McRae Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry 164 2007 1115 1117
181. P.N. Mardikian, S.D. LaRowe, S. Hedden, P.W. Kalivas, and R.J. Malcolm An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study Prog Neuropsychopharmacol Biol Psychiatry 31 2007 389 394
182. J.D. Rothstein, S. Patel, M.R. Regan, C. Haenggeli, Y.H. Huang, and D.E. Bergles Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression Nature 433 2005 73 77
183. S. Scott, J.E. Kranz, J. Cole, J.M. Lincecum, K. Thompson, and N. Kelly Design, power, and interpretation of studies in the standard murine model of ALS Amyotroph Lateral Scler 9 2008 4 15
184. B.J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O'Neill, and S.C. Fagan Neuroprotective agents for clinical trials in ALS: a systematic assessment Neurology 67 2006 20 27
185. L.A. Knackstedt, S. LaRowe, P. Mardikian, R. Malcolm, H. Upadhyaya, and S. Hedden The role of cystine-glutamate exchange in nicotine dependence in rats and humans Biol Psychiatry 65 2009 841 845
186. Y. Sari, K.D. Smith, P.K. Ali, and G.V. Rebec Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats J Neurosci 29 2009 9239 9243
187. S.M. Rawls, D.A. Baron, and J. Kim beta-Lactam antibiotic inhibits development of morphine physical dependence in rats Behav Pharmacol 21 2010 161 164
188. S.M. Rawls, F. Cavallo, A. Capasso, Z. Ding, and R.B. Raffa The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians Eur J Pharmacol 584 2008 278 284
189. B.L. Kieffer, and C.J. Evans Opioid receptors: from binding sites to visible molecules in vivo Neuropharmacology 56 Suppl 1 2009 205 212
190. L.A. Ray, P.F. Chin, and K. Miotto Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics CNS Neurol Disord Drug Targets 9 2010 13 22
191. S. Ross, and E. Peselow Pharmacotherapy of addictive disorders Clin Neuropharmacol 32 2009 277 289
192. C.L. Crunelle, M.L. Miller, J. Booij, and W. van den Brink The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review Eur Neuropsychopharmacol 20 2010 69 79
193. Z.X. Xi, and E.L. Gardner Hypothesis-driven medication discovery for the treatment of psychostimulant addiction Curr Drug Abuse Rev 1 2008 303 327
194. J.A. Monn, M.J. Valli, S.M. Massey, M.M. Hansen, T.J. Kress, and J.P. Wepsiec Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2, 6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors J Med Chem 42 1999 1027 1040
195. G. Imre The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268 CNS Drug Rev 13 2007 444 464
196. L. Lu, J.L. Uejima, S.M. Gray, J.M. Bossert, and Y. Shaham Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving Biol Psychiatry 61 2007 591 598 (Pubitemid 46343539)
197. Y. Hao, R. Martin-Fardon, and F. Weiss Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence Biol Psychiatry 68 2010 240 248
198. H. Aujla, R. Martin-Fardon, and F. Weiss Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence Neuropsychopharmacology 33 2008 1818 1826
199. J. Cartmell, J.A. Monn, and D.D. Schoepp The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats J Pharmacol Exp Ther 291 1999 161 170
200. D.A. Mitrano, C. Arnold, and Y. Smith Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the nucleus accumbens of cocaine-treated rats Neuroscience 154 2 2008 653 666
201. A.W. Ary, and K.K. Szumlinski Regional differences in the effects of withdrawal from repeated cocaine upon Homer and glutamate receptor expression: a two-species comparison Brain Res 1184 2007 295 305
202. P.J. Kenny, B. Boutrel, F. Gasparini, G.F. Koob, and A. Markou Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats Psychopharmacol Berl 179 2005 247 254
203. A.J. McGeehan, and M.F. Olive The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse Synapse 47 2003 240 242
204. N.E. Paterson, S. Semenova, F. Gasparini, and A. Markou The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice Psychopharmacol Berl 167 2003 257 264
205. P.M.t. Lea, and A.I. Faden Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP CNS Drug Rev 12 2006 149 166
206. Y. Iso, E. Grajkowska, J.T. Wroblewski, J. Davis, N.E. Goeders, and K.M. Johnson Synthesis and structure-activity relationships of 3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications J Med Chem 49 2006 1080 1100
207. O.A. Dravolina, W. Danysz, and A.Y. Bespalov Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats Psychopharmacol Berl 187 2006 397 404
208. R. Martin-Fardon, M.A. Baptista, C.V. Dayas, and F. Weiss Dissociation of the effects of MTEP [3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer J Pharmacol Exp Ther 329 2009 1084 1090
209. M.M. Norberg, J.H. Krystal, and D.F. Tolin A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy Biol Psychiatry 63 2008 1118 1126
210. F. Botreau, G. Paolone, and J. Stewart d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference Behav Brain Res 172 2006 173 178
211. J.B. Kelley, K.L. Anderson, and Y. Itzhak Long-term memory of cocaine-associated context: disruption and reinstatement Neuroreport 18 2007 777 780 (Pubitemid 46686026)
212. B.A. Nic Dhonnchadha, J.J. Szalay, C. Achat-Mendes, D.M. Platt, M.W. Otto, and R.D. Spealman d-Cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning Neuropsychopharmacology 35 2010 357 367
213. P.K. Thanos, C. Bermeo, G.J. Wang, and N.D. Volkow d-Cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice Behav Brain Res 199 2009 345 349
214. K.L. Price, A.L. McRae-Clark, M.E. Saladin, M.M. Maria, S.M. DeSantis, and S.E. Back d-Cycloserine and cocaine cue reactivity: preliminary findings Am J Drug Alcohol Abuse 35 2009 434 438
215. J.S. Ballon, and D. Feifel A systematic review of modafinil: potential clinical uses and mechanisms of action J Clin Psychiatry 67 2006 554 566
216. N.E. Paterson, A. Fedolak, B. Olivier, T. Hanania, A. Ghavami, and B. Caldarone Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents Pharmacol Biochem Behav 95 2010 449 456
217. T.M. Korotkova, B.P. Klyuch, A.A. Ponomarenko, J.S. Lin, H.L. Haas, and O.A. Sergeeva Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors Neuropharmacology 52 2007 626 633
218. V. Deroche-Gamonet, M. Darnaudery, L. Bruins-Slot, F. Piat, M. Le Moal, and P.V. Piazza Study of the addictive potential of modafinil in naive and cocaine-experienced rats Psychopharmacol Berl 161 2002 387 395
219. R.E. Bernardi, J.R. Lewis, K.M. Lattal, and S.P. Berger Modafinil reinstates a cocaine conditioned place preference following extinction in rats Behav Brain Res 204 2009 250 253
220. L.H. Gold, and R.L. Balster Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil Psychopharmacol Berl 126 1996 286 292
221. M.L. Andersen, E. Kessler, K.S. Murnane, J.C. McClung, S. Tufik, and L.L. Howell Dopamine transporter-related effects of modafinil in rhesus monkeys Psychopharmacol Berl 210 2010 439 448
222. J.L. Donovan, C.L. DeVane, R.J. Malcolm, J. Mojsiak, C.N. Chiang, and A. Elkashef Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers Clin Pharmacokinet 44 2005 753 765
223. C.A. Dackis, K.G. Lynch, E. Yu, F.F. Samaha, K.M. Kampman, and J.W. Cornish Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study Drug Alcohol Depend 70 2003 29 37
224. C.A. Dackis, K.M. Kampman, K.G. Lynch, H.M. Pettinati, and C.P. O'Brien A double-blind, placebo-controlled trial of modafinil for cocaine dependence Neuropsychopharmacology 30 2005 205 211
225. R. Malcolm, K. Swayngim, J.L. Donovan, C.L. DeVane, A. Elkashef, and N. Chiang Modafinil and cocaine interactions Am J Drug Alcohol Abuse 32 2006 577 587
226. C.L. Hart, M. Haney, S.K. Vosburg, E. Rubin, and R.W. Foltin Smoked cocaine self-administration is decreased by modafinil Neuropsychopharmacology 33 2008 761 768
227. S.K. Vosburg, C.L. Hart, M. Haney, E. Rubin, and R.W. Foltin Modafinil does not serve as a reinforcer in cocaine abusers Drug Alcohol Depend 106 2010 233 236
228. A.L. Anderson, M.S. Reid, S.H. Li, T. Holmes, L. Shemanski, and A. Slee Modafinil for the treatment of cocaine dependence Drug Alcohol Depend 104 2009 133 139
229. K.S. Smith, A.J. Tindell, J.W. Aldridge, and K.C. Berridge Ventral pallidum roles in reward and motivation Behav Brain Res 196 2009 155 167